South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER)
Project Number1R01ES035388-01A1
Former Number1R01ES035388-01
Contact PI/Project LeaderRACETTE, BRAD A
Awardee OrganizationST. JOSEPH'S HOSPITAL AND MEDICAL CENTER
Description
Abstract Text
Abstract
Manganese (Mn) is a well-established neurotoxicant that likely induces neurodegeneration through
inflammatory pathways. Millions of people worldwide experience high levels of environmental Mn from point
source emissions or associated fugitive dust. In the first five years of the SMELTER (South African
Manganese EnvironmentaL NeuroToxic Effects Research) study, we assembled a cohort of >800 Black
African residents, including >700 exposed to Mn emissions from one of the world’s largest Mn smelters in
Meyerton, South Africa. We developed and validated study assessment tools in the appropriate South African
languages, measured environmental Mn in Meyerton and a comparable non-exposed reference community
(Ethembalethu), examined participants using the Unified Parkinson Disease Rating Scale motor subsection
part 3 (UPDRS3), and evaluated participants using targeted cognitive and mood assessments. We
demonstrated that Meyerton residents had markedly poorer performance in these outcomes as compared to
Ethembalethu residents. These neurological health effects were associated with concentrations ~100-200
ng/m3 of Mn as particulate matter (PM) <2.5 µm in diameter (PM2.5-Mn), a level consistent with other point
sources throughout the world. In this proposal, we will build on these accomplishments by investigating
whether Mn exposure is also associated with progression of the observed motor and cognitive health effects
in this same cohort and to estimate longitudinal, in addition to cross-sectional, associations. We successfully
employed this approach in our studies of Mn-exposed welders in the U.S. in whom longitudinal studies were
required to show dose-response effects. To better characterize Mn exposure and mechanism of neurotoxicity,
we will incorporate brain magnetic resonance imaging (MRI), including sequences designed to assess
neuroinflammation. We will also expand our air monitoring to explore the contribution of PM size on motor,
cognitive, and non-motor health outcomes, as well as neuroinflammation as assessed by brain MRI. Finally,
we will implement a dissemination plan to inform community and national stakeholders of study results. Our
overarching hypothesis is that environmental Mn exposure two orders of magnitude below contemporary
occupational exposure is associated with progression of both parkinsonism and cognitive dysfunction and that
neuroinflammation mediates the relationship between environmental Mn exposure and clinical neurotoxicity.
We further hypothesize that particle sizes <1µm (i.e., the more inspirable particles within PM2.5) will be more
strongly associated with clinical outcomes than larger sizes. Accomplishing these aims will inform
international environmental Mn regulations and will address an important environmental justice concern
identified by a community of participants typically underrepresented in environmental health research. The
proposed aims address the NIEHS strategic theme, “Promoting Translation – Data to Knowledge to Action.”
Public Health Relevance Statement
Project Narrative
Manganese (Mn) is a well-established neurotoxicant and millions of people worldwide are exposed to high
levels of environmental Mn from point source emissions or associated fugitive dust. In this proposal, we will
investigate associations between environmental Mn exposure and motor, cognitive, and brain MRI imaging
outcomes in an established African cohort. If successful, accomplishing these aims will inform environmental
regulation of Mn exposure worldwide.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountingAddressAfricanAirAssessment toolAttenuatedAwarenessBackBlack raceBrainClinicalClinical assessmentsCognitiveCommunitiesCross-Sectional StudiesDataDiameterDiffusionDiffusion Magnetic Resonance ImagingDoseDustEducationEncephalitisEnvironmental HealthEquilibriumExposure toGaitGeographyHealthImageImpaired cognitionInflammatoryInternationalKnowledgeLanguageLiquid substanceLongitudinal StudiesMagnetic Resonance ImagingManganeseManualsMeasuresMediatingMoodsMotivationMotorMovement Disorder Society Unified Parkinson's Disease Rating ScaleNational Institute of Environmental Health SciencesNerve DegenerationNeurologicNeurological outcomeNeurologistNeurotoxinsOccupationalOccupational ExposureOutcomeOutcome AssessmentParkinson DiseaseParkinsonian DisordersParticipantParticle SizeParticulate MatterPathway interactionsPennsylvaniaPerformancePersonsPhenotypePolicy MakerPublic HealthQuestionnairesRecoveryRegulationRelaxationResearchSamplingSmell PerceptionSourceSouth AfricaSouth AfricanTestingTranslationsUniversitiesWorkair monitoringbrain magnetic resonance imagingcognitive controlcohortdata to knowledgedesigndexterityenvironmental justiceexperiencefine particlesliteracylongitudinal analysismeetingsmetermultimodalityneuroinflammationneurotoxicneurotoxicitynon-motor symptomparticlepreferenceresponsescientific literacyspectrographvalidation studies
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
131606022
UEI
SKX6AXF9ZTM3
Project Start Date
01-September-2024
Project End Date
30-June-2029
Budget Start Date
01-September-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$585,531
Direct Costs
$496,970
Indirect Costs
$88,561
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$585,531
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01ES035388-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01ES035388-01A1
Patents
No Patents information available for 1R01ES035388-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01ES035388-01A1
Clinical Studies
No Clinical Studies information available for 1R01ES035388-01A1
News and More
Related News Releases
No news release information available for 1R01ES035388-01A1
History
No Historical information available for 1R01ES035388-01A1
Similar Projects
No Similar Projects information available for 1R01ES035388-01A1